According to Kintara Therapeutics latest financial reports the cash on hand of KTRA is $1.53M, an decrease of -86.97% to 2022. At the end of 2022 company had $11.78M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $1.53M | -86.97% |
2022 | $11.78M | 11.80% |
2021 | $10.54M | 340.51% |
2020 | $2.39M | -35.68% |
2019 | $3.72M | - |